Login  
Volume 66
January 2005
Number 01

Original Articles   [top]

7  Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity

[Full Text]

15  The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation

[Full Text]

28  Sertraline Treatment of Pathological Gambling: A Pilot Study

[Full Text]

34  Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

[Full Text]

41  Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

[Full Text]

49  The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

[Full Text]

52  Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders

[Full Text]

63  A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety

[Full Text]

73  Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

[Full Text]

80  Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

[Full Text]

85  A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

[Full Text]

94  Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline

[Full Text]

100  Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine

[Full Text]

107  Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

[Full Text]

111  A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

[Full Text]

Academic Highlights   [top]

122  Academic Highlights: Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

[Full Text]

Letters To the Editor   [top]

134  Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

[Full Text]

134  Interactions of Cyclobenzaprine and Tricyclic Antidepressants

[Full Text]

135  Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

[Full Text]

135  Problems in Assessing Musical Hallucinations

[Full Text]

136  Reply to Problems in Assessing Musical Hallucination

[Full Text]

137  Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics. James L. Karagianis and Eduardo Dunayevich

[Full Text]

138  Reply to "Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics."

[Full Text]

Book Reviews   [top]

139  Becoming a Therapist: What Do I Say, and Why?

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx